The nature of the prostaglandin-blocking activity of polyphloretin phosphate.
D000109:Acetylcholine / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D000804:Angiotensin II / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D000818:Animals; D001920:Bradykinin / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D003106:Colon / Q000187:drug effects* / Q000502:physiology; D004336:Drug Antagonism; D005849:Gerbillinae; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010693:Phloretin / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology*; D010696:Phloroglucinol / Q000494:pharmacology*; D010756:Phosphoric Acids / Q000494:pharmacology; D011108:Polymers / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology*; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000008:administration & dosage; D051381:Rats
D010756:Phosphoric Acids; D011108:Polymers; D011427:Propiophenones; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000804:Angiotensin II; D010695:Phlorhizin; D010696:Phloroglucinol; D000109:Acetylcholine; D010693:Phloretin; D001920:Bradykinin